2023
DOI: 10.1002/adma.202304514
|View full text |Cite
|
Sign up to set email alerts
|

Manganese‐Based Nanoparticle Vaccine for Combating Fatal Bacterial Pneumonia

Xuan OuYang,
Xican Xu,
Qingqing Qin
et al.

Abstract: Bacterial pneumonia is the leading cause of death worldwide among all infectious diseases. However, currently available vaccines against fatal bacterial lung infections, including pneumonic plague, are accompanied by limitations, including insufficient antigen‐adjuvant co‐delivery and inadequate immune stimulation. Therefore, there is an urgent requirement to develop next‐generation vaccines to improve the interaction between antigen and adjuvant, as well as enhance the effects of immune stimulation. Our study… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 40 publications
0
4
0
Order By: Relevance
“…Compared with the other treatment groups, the FZOH + αPD-1 treatment group exhibited significantly greater maturation of DCs (Figure B,C). Mature DCs effectively present antigens and activate T cells . Therefore, the proportions of CD4 + and CD8 + T cells in the FZOH and FZOH + αPD-1 treatment groups increased, especially in the FZOH + αPD-1 group (Figure D,E).…”
Section: Resultsmentioning
confidence: 89%
See 1 more Smart Citation
“…Compared with the other treatment groups, the FZOH + αPD-1 treatment group exhibited significantly greater maturation of DCs (Figure B,C). Mature DCs effectively present antigens and activate T cells . Therefore, the proportions of CD4 + and CD8 + T cells in the FZOH and FZOH + αPD-1 treatment groups increased, especially in the FZOH + αPD-1 group (Figure D,E).…”
Section: Resultsmentioning
confidence: 89%
“…Mature DCs effectively present antigens and activate T cells. 43 Therefore, the proportions of CD4 + and CD8 + T cells in the FZOH and FZOH + αPD-1 treatment groups increased, especially in the FZOH + αPD-1 group (Figure 7D,E). The release of DAMPs by FZOH-induced immunogenic cell death promoted antigen presentation and stimulated DC maturation.…”
Section: Acsmentioning
confidence: 88%
“…27−29 Through the coordination of manganese ions and imidazole groups, scientists have developed a variety of pH-sensitive coordination nanomaterials, which have promising applications in protein delivery and immunotherapy. 30,31 Synthetic polypeptide is one of the candidate materials for drug delivery because of its desirable biocompatibility, biodegradability, and unique secondary conformations, and some polypeptide nanomedicines and hydrogels have entered clinical trials. 32,33 In the antigen delivery and immunotherapy fields, our group previously prepared photoresponsive vesicles by glycosylated polypeptide amphiphiles for antigen delivery, and the glucose-coated polypeptide vesicles effectively delivered antigen into cells and triggered release through UV-irradiation-induced morphology transformation, thus activating a cellular immune response.…”
Section: ■ Introductionmentioning
confidence: 99%
“…It is believed that manganese ions can increase the sensitivity of cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) to double-stranded DNA and promote stimulator of interferon gene (STING) activation, i.e., as an agonist of the cGAS-STING pathway. For example, Jiang et al discovered manganese ions played dual functions of alarmin and agonist in the cGAS-STING pathway, promoting the secretion of type I interferon, then recruiting professional immune cells such as macrophages, dendritic cells, and lymphocytes and promoting the maturation and antigen presentation of dendritic cells, thereby activating immunity. Through the coordination of manganese ions and imidazole groups, scientists have developed a variety of pH-sensitive coordination nanomaterials, which have promising applications in protein delivery and immunotherapy. , …”
Section: Introductionmentioning
confidence: 99%